Discovery of novel pathways and therapuetic targets for the treatment of MS and other neurodegenerative diseases

Project Details

StatusFinished
Effective start/end date10/07/13 → 31/12/16

Funding

  • Non-EU industry, commerce and public corporations: £512,033.00